Table 1.

Thirty most abundant miRNAs in NOSE and their average relative expression

miRNA	% miRNA population
hsa-let-7f	38.57
hsa-let-7a	20.12
hsa-mir-21	5.38
hsa-let-7g	4.87
hsa-let-7b	3.48
hsa-mir-103	2.85
hsa-mir-140-3p (−6.6)	2.83
hsa-let-7e	2.38
hsa-mir-31	2.33
hsa-mir-29a	2.06
hsa-let-7d	1.65
hsa-mir-320a	1.13
hsa-mir-191	1.09
hsa-mir-221	0.74
hsa-mir-100 (−117.7)	0.73
hsa-let-7i (+4.3)	0.67
hsa-mir-222	0.63
hsa-let-7c	0.52
hsa-mir-107	0.52
hsa-mir-152	0.52
hsa-mir-181a	0.48
hsa-mir-30a (+8.1)	0.39
hsa-mir-101	0.38
hsa-mir-423–5p	0.36
hsa-mir-130a	0.33
hsa-mir-22 (−7.0)	0.31
hsa-mir-24	0.28
hsa-mir-99b (−2.9)	0.27
hsa-mir-26a	0.23
hsa-mir-378	0.20

miRNAs in bold were aberrantly expressed in clear cell ovarian cancer, and their fold change in cancer vs. normal is in parentheses.